AI-ECG Tracker vs DeepRhythmAI
AI Verdict
Choose AI-ECG Tracker if…
Choose AI-ECG Tracker if your organization requires a robust on-premise solution for rapid, comprehensive 12-lead ECG auto-analysis, offering high accuracy across a broad spectrum of cardiac conditions including arrhythmias, myocardial ischemia, and ventricular hypertrophy. This tool is ideal for facilities prioritizing local data processing with powerful GPU computing for quick diagnoses, while also offering an optional cloud service for remote diagnostic capabilities.
View AI-ECG Tracker →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your primary focus is on revolutionizing cardiac arrhythmia detection and classification through a highly accurate, cloud-based AI algorithm. This device-agnostic solution is perfect for healthcare providers aiming to significantly reduce missed arrhythmia diagnoses and streamline clinical workflows by integrating seamlessly with various ECG devices.
View DeepRhythmAI →For physicians evaluating AI tools for ECG analysis, AI-ECG Tracker and DeepRhythmAI offer distinct approaches. AI-ECG Tracker, from Shenzhen Carewell Electronics Co., excels in comprehensive, rapid auto-diagnosis across 16 cardiac classifications and 104 ECG diagnostic classifications, including arrhythmias, hypertrophy, and ischemia. Its on-premise deployment with an optional cloud service provides a robust workstation for detailed review and report generation, making it suitable for practices prioritizing a dedicated, high-speed local processing unit for a broad spectrum of ECG interpretations.
DeepRhythmAI, by Medicalgorithmics S.A., specializes in highly accurate, cloud-based arrhythmia detection and classification. Leveraging advanced CNN and Transformer models trained on an extensive dataset of over 250 billion heartbeats, it focuses on refining arrhythmia diagnostics and significantly reducing missed diagnoses. Its device-agnostic, cloud-based nature and API availability make it ideal for practices seeking a flexible, integrated solution to enhance workflow efficiency specifically for arrhythmia analysis across various ECG devices.
The key practical difference lies in their deployment and diagnostic scope: AI-ECG Tracker offers a comprehensive, workstation-centric solution for a wide range of ECG abnormalities, while DeepRhythmAI provides a specialized, cloud-based, and device-agnostic service for superior arrhythmia detection. Physicians needing a broad, on-site ECG auto-analysis tool might favor AI-ECG Tracker. In contrast, those prioritizing highly accurate, streamlined, and flexible arrhythmia detection with cloud integration should consider DeepRhythmAI.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-ECG Tracker | DeepRhythmAI |
|---|---|---|
| Pricing | Not publicly available | Enterprise |
| Deployment | On-premise (AI-ECG Workstation, Diagnostic Client) with optional cloud service (Lepu Nebula Cloud) for remote diagnostic services. | Cloud |
| FDA Status | 1 AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepRhythmAITool B, DeepRhythmAI, is cloud-based and device-agnostic with an API available, suggesting easier integration and broader compatibility across various ECG devices and existing workflows. While Tool A offers both on-premise and cloud options with a rapid diagnosis time, Tool B's focus on streamlining clinical workflows by up to 65% and its device-agnostic nature generally point to higher overall usability and accessibility for a wider range of users.
Clinical Value
DeepRhythmAIBoth tools are FDA-cleared, establishing a baseline for clinical validity. However, DeepRhythmAI (Tool B) demonstrates superior clinical value by explicitly stating it was trained on an exceptionally large dataset of 250 billion+ annotated heartbeats and quantifies its impact by reducing missed diagnoses 14x to 114x fewer. While AI-ECG Tracker (Tool A) claims over 95% accuracy and supports 104 classifications, Tool B's specific, high-impact clinical outcomes backed by extensive training data give it an edge.
Pricing & Value
DeepRhythmAIThe pricing for both tools is not publicly available, making a direct cost comparison impossible. However, DeepRhythmAI (Tool B) provides clear, quantified benefits such as streamlining clinical workflows by up to 65% and reducing missed diagnoses by 14x to 114x. These explicit and significant efficiency gains and improvements in diagnostic accuracy offer a more tangible and compelling value proposition compared to the general accuracy claims of AI-ECG Tracker (Tool A).
Enterprise Readiness
DeepRhythmAIDeepRhythmAI (Tool B) explicitly targets 'Solo to large health systems' and offers an API for integration and data export capabilities, which are crucial for enterprise adoption and scalability. While AI-ECG Tracker (Tool A) offers flexible hybrid deployment and a web-based management portal, its HIPAA and BAA compliance are stated as 'likely' rather than explicitly confirmed for the product, which could be a concern for large enterprises.
Innovation
DeepRhythmAIDeepRhythmAI (Tool B) showcases a more advanced and scalable technological approach by explicitly mentioning the utilization of modern AI architectures like CNN and Transformer models, trained on an exceptionally large dataset of 250 billion+ annotated heartbeats. This leads to superior performance metrics, such as a significant reduction in missed diagnoses. While AI-ECG Tracker (Tool A) is a pioneer in AI ECG auto-diagnosis and offers rapid analysis, Tool B's detailed technological foundation and quantified impact demonstrate a higher degree of current innovation.
Support & Docs
TieNeither the provided structured facts nor web searches yielded specific, detailed information regarding product-level support channels, service level agreements (SLAs), or comprehensive public documentation (like user manuals or extensive FAQs) for either AI-ECG Tracker or DeepRhythmAI. Both parent companies (Lepu Medical and Medicalgorithmics S.A.) offer general contact information, but a direct comparison of their AI tool-specific support and documentation is not possible with the available data.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-ECG Tracker | DeepRhythmAI |
|---|---|---|
| Company | Shenzhen Carewell Electronics Co. | Medicalgorithmics S.A. |
| Core AI Function | AI-powered ECG auto-analysis and diagnosis for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; supports 12-lead ECG data collection. | AI-powered arrhythmia detection and classification from ECG data, utilizing CNN and Transformer models. |
| Stated Accuracy/Impact | High accuracy (over 95%) for common cardiac abnormalities | Reduces missed diagnoses (14x to 114x fewer) |
| Target Specialties | Cardiology, Emergency Medicine | Cardiology |
| Diagnosis/Analysis Speed | Rapid diagnosis in approximately 3 seconds | Faster ECG reporting and analysis; streamlines clinical workflows (up to 65% efficiency increase) |
Videos
Demos, reviews, and walkthroughs featuring AI-ECG Tracker and DeepRhythmAI.